Sign up to save your podcasts
Or
Share Anti-VEGF AMD Trials
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Anti-VEGF AMD Trials
This week, we review the major flagship anti-VEGF agents, pegaptinib, ranibizumab, bevacizumab, aflibercept, as well as some of the flagship clinical trials, including VISION, MARINA, ANCHOR, CATT, and VIEW 1 and 2.
Also, we are doing a survey to assess the impact of the podcast. If you'd like to support us, take this 4 minute survey: bit.ly/2VpPRND
View all episodes
By Ben Young and Andrew Pouw
4.9
275275 ratings
This week, we review the major flagship anti-VEGF agents, pegaptinib, ranibizumab, bevacizumab, aflibercept, as well as some of the flagship clinical trials, including VISION, MARINA, ANCHOR, CATT, and VIEW 1 and 2.
Also, we are doing a survey to assess the impact of the podcast. If you'd like to support us, take this 4 minute survey: bit.ly/2VpPRND
More shows like Eyes For Ears
View all
This American Life
91,036 Listeners
Ophthalmology off the Grid by Eyetube
43 Listeners
New Retina Radio by Eyetube
18 Listeners
Straight From The Cutter's Mouth: A Retina Podcast
97 Listeners
White Coat Investor Podcast
2,441 Listeners
Up First from NPR
56,404 Listeners
The Diary Of A CEO with Steven Bartlett
8,625 Listeners
Huberman Lab
29,173 Listeners
Pupil Pod
10 Listeners
Experts InSight
52 Listeners
Scamfluencers
7,332 Listeners
Continuum Audio
79 Listeners
Ophthalmology Journal
18 Listeners
Mayo Clinic Ophthalmology Podcast
19 Listeners
Two eyes in a pod
0 Listeners